This episode looks at the way biotech addressed the COVID crisis and explores how the crisis, in turn, changed the biotech industry—its reputation, its exposure to a broader audience and its willingness to adopt lessons learned from the pandemic.

This episode explores the recommendations and best solutions to address global distribution challenges and questions a simplistic proposal offered by some countries to the WTO.